Neumora Therapeutics Inc (NMRA)’s stock has witnessed a price hike of 2.66% from the previous close with its current price standing at $1.9. Its current price is -88.95% under its 52-week high of $17.19 and 210.85% more than its 52-week low of $0.61.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, NMRA’s SMA-200 is $4.6697.
NMRA’s price to book ratio for the most recent quarter was 1.35, resulting in an 1.23 price to cash per share for the period.
How does Neumora Therapeutics Inc (NMRA) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Neumora Therapeutics Inc (NMRA): Earnings History
If we examine Neumora Therapeutics Inc’s recent earnings history, in the last quarter ended on 3/31/2025, it posted adjusted earnings per share of -$0.42, beating the consensus of -$0.38. In other words, it beat the consensus by -$0.04, resulting in a -10.04% surprise. In the 3 months period before the previous quarter which was closed on 3/31/2025, the stock recorded adjusted earnings per share of -$0.42 in contrast with the Outlook of -$0.38. That was a difference of -$0.04 and a surprise of -10.04%.
Neumora Therapeutics Inc (NASDAQ: NMRA) Ownership Details
I will give a breakdown of the key shareholders in Neumora Therapeutics Inc (NMRA). Recent figures show that the company’s insiders hold 27.57% of shares. A total of 156 institutional investors hold shares in the company, making 60.19% of its stock and 83.10% of its float.
Mar 31, 2025 , it was reported that the Company’s largest institutional holder is Softbank Group Corporation holding total of 6.54 shares that make 4.04% of the company’s total number of shares and are currently priced at 12.3 million.
The securities firm Blackrock Inc. holds 6.35 shares of NMRA, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 3.93% , and the holding percentage of shares is valued at 11.95 million.
An overview of Neumora Therapeutics Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Neumora Therapeutics Inc (NMRA) traded 2,158,552 shares per day, with a moving average of $1.0932 and price change of +1.1793. With the moving average of $0.9011 and a price change of +1.3128, about 1,410,349 shares changed hands on average over the past 50 days. Finally, NMRA’s 100-day average volume is 1,263,204 shares, alongside a moving average of $0.9542 and a price change of +0.3050.
